Optimization of SUV with Changing the Dose Amount in F18-FDG
PET/CT of Pediatric Lymphoma Patients
-
Published:2023-06
Issue:2
Volume:16
Page:151-157
-
ISSN:1874-4710
-
Container-title:Current Radiopharmaceuticals
-
language:en
-
Short-container-title:CRP
Author:
Gülaldi Nedim Cüneyt Murat1ORCID,
Cagdas Berkay1ORCID,
Görtan Fatma Arzu1ORCID
Affiliation:
1. Department of Nuclear Medicine, Ministry of Health, Ankara City Hospital, Ankara, Türkiye
Abstract
Aims:
We aim to reveal an effect of residual activity leftover within the medical materials
other than the empty syringe used for injection of the tracer on SUV measurements and consequently
effect on possible treatment response assessment.
Background:
Staging and follow-up of pediatric lymphoma patients mainly achieved by the help
of PET/CT scans. It is crucial to make an optimal imaging technique for interpreting individual
images and assessing treatment response.
Objective:
Standardized uptake value measurement is an important quantification parameter in
PET/CT scanning of childhood lymphomas. Low dose of activity used in pediatric oncology patients
makes them vulnerable to small changes of input values for subsequent metabolic parameters.
Methods:
Sixty-eight pediatric lymphoma patients below 50 kg were included into the study. SUVmax,
SUVpeak values of the most metabolically active lesions, along with liver and mediastinum,
were recorded. Metabolic parameters of the lesions/lymph nodes, mediastinum and liver parenchyma
were compared before and after counts from medical materials other than empty syringe
were taken into account. Wilcoxon signed-rank test was used for non-parametric paired sampled
tests for the groups.
Results:
There were statistically significant differences between the whole 6 above-mentioned
groups confirming the importance of residual counts on metabolic parameters (p < 0.001).
Conclusion:
Our study demonstrated residual radioactivity in medical materials such as serum
line tubes, i.v. catheters, three-way stopcock and also butterfly needles used during intravenous
injection should also be included for optimum quantitative metabolic parameter values and to minimize
its the adverse effect on treatment response evaluation, especially in borderline lesions.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Radiology, Nuclear Medicine and imaging